No Data
No Data
What the Options Market Tells Us About Bristol-Myers Squibb
Deep-pocketed investors have adopted a bearish approach towards Bristol-Myers Squibb (NYSE:BMY), and it's something market players shouldn't ignore. Our tracking of public options records at
Bristol Myers Squibb Validates Net-Zero Goals Through Science Based Targets Initiative
Bristol Myers Squibb (BMY) said Thursday it has validated its near-term and longer-term targets to lower greenhouse emissions throughout its value chain to net-zero by 2050 through the Science Based
Bristol-Myers Squibb Options Spot-On: On July 17th, 77,366 Contracts Were Traded, With 827.89K Open Interest
On July 17th ET, $Bristol-Myers Squibb(BMY.US)$ had active options trading, with a total trading volume of 77,366 options for the day, of which put options accounted for 20.95% of the total
Big Pharma Rally After J&J Earnings
US Bancorp Posts Upbeat Earnings, Joins Aehr Test Systems, Hancock Whitney And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were mixed, with the Dow Jones index gaining around 150 points on Wednesday.Shares of U.S. Bancorp (NYSE:USB) shares rose during Wednesday's session following a second-quarter earnings
Bristol-Myers Squibb Up Over 5%, on Pace for Largest Percent Increase Since November 2020 -- Data Talk
Bristol-Myers Squibb Company (BMY) is currently at $43.36, up $2.16 or 5.24% --Would be highest close since May 20, 2024, when it closed at $43.36 --On pace for largest percent increase since Nov. 4,
No Data
100k : You are everywhere
TrendTraderOP 100k: I try![wink 😉](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f609.png)